ComboCap is renowned for the invention and commercialization of Side-by-side technology, which is a three-piece capsule containing an internal divider that enables wet and dry ingredients to be brought to market side-by-side.
Vantage Nutrition (Chadds Ford, PA), an ACG group company, has announced full shareholding ownership of ComboCap Inc. (Whippany, NJ) and South Africa-based BioCap. ComboCap is renowned for the invention and commercialization of Side-by-side technology, which is a three-piece capsule containing an internal divider that enables wet and dry ingredients to be brought to market side-by-side. This is Vantage Nutrition’s second U.S. investment in less than a year, and the first in South Africa, following its acquisition of AquaCap from Nestlé S.A in December 2022.
“Strengthening our portfolio of most comprehensive vegetarian and gelatin capsules, in every imaginable size, I am thrilled to announce the acquisition of ComboCap Inc and BioCap. We now will hold the patented design and specialized equipment used in producing the world’s first 2-in-1 capsule product with a movable membrane, becoming the sole proprietor of this technology globally,” said Karan Singh, managing director at ACG, in a press release. “With our partners, we will usher a new era in new combinations of dietary supplements, and even non-prescription or over-the counter (OTC) remedies as well as prescription (Rx) medicines to be delivered in a single dose. This technological breakthrough is a solution to current formulation challenges with many combination therapies, including incompatible ingredients or molecules. Capsules are arguably the safest and most reliable way to deliver medicine and we at ACG strive to make it better.”